Received Apr 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 5H95B | IM / RL |
At the age of 11 months, patient received kinrix (which is only approved for age 4y-6y). Patient did not suffer any side effects or adverse effects from this administration error. No treatment was needed.
None
None
None
None
none